Letters to the Editor
Perioperative Beta Blockers for Patients with Diabetes
Am Fam Physician. 2003 Sep 1;68(5):802.
to the editor: I found Dr. Marks' article, “Perioperative Management of Diabetes,”1 to be a useful guide for the perioperative management of diabetic medications. Because diabetes is a significant risk factor for cardiac complications, it is important to remind readers that perioperative beta blockers are often indicated in these patients. The use of a perioperative beta blocker in patients with major risk factors for coronary artery disease is a class IIa recommendation by the American College of Cardiology/American Heart Association.2 An excellent review3 on the indications, contraindications, and methods of perioperative beta blockade was published recently. Diabetes mellitus requiring insulin therapy is a Cardiac Risk Index Criteria and is an indication for beta blockade. Diabetes that does not require insulin is a minor criteria, and, in conjunction with age greater than 65 years, hypertension, current smoking, or total cholesterol level more than 240, also is an indication for beta blockade.
1. Marks JB. Perioperative management of diabetes. Am Fam Physician. 2003;67:93–100.
2. Eagle KA, Gibbons RJ, Antman EM, Berger PB, Calkins H. ACC/AHA guideline update on perioperative cardiovascular evaluation for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Available at: www.acc.org/clinical/guidelines/perio/update/pdf/perio_update.pdf.
3. Auerbach AD, Goldman L. Beta-blockers and reduction of cardiac events in noncardiac surgery: scientific review. JAMA. 2002;287:1435–44.
in reply: Dr. Chambliss makes an important point. However, discussion of the use of any medications, other than those directed at maintaining glycemic and metabolic homeostasis in the diabetic perioperative patient, was beyond the scope of my paper. I agree with the use of beta blockers in patients with diabetes who require insulin and are at risk for coronary artery disease. Dr. Chambliss' reminder to review this separate topic is timely.
Send letters to email@example.com, or 11400 Tomahawk Creek Pkwy., Leawood, KS 66211-2680. Include your complete address, e-mail address, and telephone number. Letters should be fewer than 400 words and limited to six references, one table or figure, and three authors.
Letters submitted for publication in AFP must not be submitted to any other publication. Possible conflicts of interest must be disclosed at time of submission. Submission of a letter will be construed as granting the AAFP permission to publish the letter in any of its publications in any form. The editors may edit letters to meet style and space requirements.
This series is coordinated by Kenny Lin, MD, MPH, Associate Deputy Editor for AFP Online.
Copyright © 2003 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact firstname.lastname@example.org for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions